1
|
Shi Q, He J, Chen G, Xu J, Zeng Z, Zhao X, Zhao B, Gao X, Ye Z, Xiao M, Li H. The chemical composition of Diwu YangGan capsule and its potential inhibitory roles on hepatocellular carcinoma by microarray-based transcriptomics. J Tradit Complement Med 2024; 14:381-390. [PMID: 39035694 PMCID: PMC11259662 DOI: 10.1016/j.jtcme.2023.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 09/28/2023] [Accepted: 12/24/2023] [Indexed: 07/23/2024] Open
Abstract
The Traditional Chinese Medicine compound preparation known as Diwu Yanggan capsule (DWYG) can effectively hinder the onset and progression of hepatocellular carcinoma (HCC), which is recognized worldwide as a significant contributor to fatalities associated with cancer. Nevertheless, the precise mechanisms implicated have remained ambiguous. In present study, the model of HCC was set up by the 2-acetylaminofluorene (2-AAF)/partial hepatectomy (PH) in rats. To confirm the differentially expressed genes (DEGs) identified in the microarray analysis, real-time quantitative reverse transcription PCR (qRT-PCR) was conducted. In the meantime, the liquid chromatography-quadrupole time of flight mass spectrometry (LC-QTOF-MS/MS) was employed to characterize the component profile of DWYG. Consequently, the DWYG treatment exhibited the ability to reverse 51 variation genes induced by 2-AAF/PH. Additionally, there was an overlap of 54 variation genes between the normal and model groups. Upon conducting RT-qPCR analysis, it was observed that the expression levels of all genes were increased by 2-AAF/PH and subsequently reversed after DWYG treatment. Notably, the fold change of expression levels for all genes was below 0.5, with 3 genes falling below 0.25. Moreover, an investigation was conducted to determine the signaling pathway that was activated/inhibited in the HCC group and subsequently reversed in the DWYG group. Moreover, the component profile of DWYG encompassed a comprehensive compilation of 206 compounds that were identified or characterized. The findings of this study elucidated the potential alleviative mechanisms of DWYG in the context of HCC, thereby holding significant implications for its future clinical utilization and widespread adoption.
Collapse
Affiliation(s)
- Qingxin Shi
- School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China
| | - Jiangcheng He
- Wuhan Integrated Traditional Chinese and Western Medicine Orthopedic Hospital, Affiliated Hospital of Wuhan Sports University, Wuhan, 430079, China
| | - Guangya Chen
- School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China
| | - Jinlin Xu
- School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China
| | - Zhaoxiang Zeng
- School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China
| | - Xueyan Zhao
- School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China
| | - Binbin Zhao
- School of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, 430065, China
| | - Xiang Gao
- Institute of Liver Diseases, Hubei Key Laboratory of the Theory and Application Research of Liver and Kidney in Traditional Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China
- Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430074, China
- Hubei Province Academy of Traditional Chinese Medicine, Wuhan, 430074, China
| | - Zhihua Ye
- Institute of Liver Diseases, Hubei Key Laboratory of the Theory and Application Research of Liver and Kidney in Traditional Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China
- Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430074, China
- Hubei Province Academy of Traditional Chinese Medicine, Wuhan, 430074, China
| | - Mingzhong Xiao
- Institute of Liver Diseases, Hubei Key Laboratory of the Theory and Application Research of Liver and Kidney in Traditional Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China
- Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430074, China
- Hubei Province Academy of Traditional Chinese Medicine, Wuhan, 430074, China
| | - Hanmin Li
- Institute of Liver Diseases, Hubei Key Laboratory of the Theory and Application Research of Liver and Kidney in Traditional Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China
- Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430074, China
- Hubei Province Academy of Traditional Chinese Medicine, Wuhan, 430074, China
| |
Collapse
|
2
|
Characteristics of the intestinal bacterial microbiota profiles in Bifidobacterium pseudocatenulatum LI09 pre-treated rats with D-galactosamine-induced liver injury. World J Microbiol Biotechnol 2023; 39:43. [DOI: 10.1007/s11274-022-03495-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Accepted: 12/09/2022] [Indexed: 12/23/2022]
|
3
|
Li Y, Li HM, Li ZC, Yang M, Xie RF, Ye ZH, Gao X, Zhou X. Ingredients, Anti-Liver Cancer Effects and the Possible Mechanism of DWYG Formula Based on Network Prediction. Onco Targets Ther 2020; 13:4213-4227. [PMID: 32523357 PMCID: PMC7237122 DOI: 10.2147/ott.s238901] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2019] [Accepted: 03/18/2020] [Indexed: 11/23/2022] Open
Abstract
Background Hepatitis virus infection plays a critical role in liver cancer initiation and development; so the purpose of this study was to investigate the anti-liver cancer effects of DiWuYangGan (DWYG) which was effective for hepatitis. Methods Network predictions were performed. Next, several tests, including HPLC, Caco-2 absorption models, MMT, protein chip, Western blotting and H22-tumor-bearing mouse, were carried out to investigate the effects and possible mechanism of DWYG. Results Network results showed DWYG might be involved in some processes such as STAT cascade. Some target genes may correspondingly participate in these procedures, such as IL-6, CASP3, AKT1, PPAR, and TP53. Diseases associated with DWYG formula may be liver cancer and hepatitis. Potential active compounds might be CUR and ISO. Chemical analysis results showed that ingredients in the formula, including DEO, SCHB, SOLA, SOLB, SCHA, LIQ, ISO, POT, and CHL, could be determined, indicating that DWYG samples for the following experiments were controllable and consistent. Caco-2 absorption of ingredients in DWYG, including DEO, SCHB, SOLA, SOLB, and LIQ, worked very well. In vitro experiment results showed that DWYG could inhibit the growth of cell lines and its effective ingredients might be SCHB, SOLB, SINA, SINB, SOLB, CUR, DEM, BIS, and GER. Further protein results showed that DWYG could upregulate the expressions of some proteins, including ERK1/2, AKT Ser473, BAD Ser112, PRAS40, Thr246, P38, Gsk-3β, and Ser9. In vivo experiment results showed that DWYG could shrink tumor size, recover ALT and AST, and decrease IL-6 levels. Their possible mechanism might be through the JAK/STAT3 pathway. Conclusion Besides the known pharmacological function of anti-hepatitis, DWYG extract expressed anti-liver cancer effects and the results were consistent partly with network predictions. ![]()
Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: https://youtu.be/bDMyKJpiig0
Collapse
Affiliation(s)
- Yao Li
- Pharmacy, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai 200032, People's Republic of China
| | - Han-Min Li
- Hepatology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, People's Republic of China
| | - Zhi-Cheng Li
- Surgery, Shanghai Pu Dong Hospital, Shanghai 201300, People's Republic of China
| | - Ming Yang
- Pharmacy, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai 200032, People's Republic of China
| | - Rui-Fang Xie
- Pharmacy, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai 200032, People's Republic of China
| | - Zhi Hua Ye
- Hepatology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, People's Republic of China
| | - Xiang Gao
- Hepatology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430061, People's Republic of China
| | - Xin Zhou
- Pharmacy, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai 200032, People's Republic of China
| |
Collapse
|
4
|
Wang M, Ye Q, Mao D, Li H. Research Progress in Liver-Regenerating Microenvironment and DNA Methylation in Hepatocellular Carcinoma: The Role of Traditional Chinese Medicine. Med Sci Monit 2020; 26:e920310. [PMID: 32144233 PMCID: PMC7077739 DOI: 10.12659/msm.920310] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
The development, progression, recurrence, and metastasis of hepatocellular carcinoma (HCC) are closely associated with an abnormal liver-regenerating microenvironment (LRM). Therefore, preventing and reversing an abnormal LRM is a potential therapeutic strategy against HCC. Studies are increasingly focusing on the impact of regeneration, fibrosis, angiogenesis, inflammation, immunomodulation, and hepatic stem cells on HCC development and progression. As a key epigenetic mechanism, DNA methylation is extensively involved in regulating physiological and pathological pathways. In this review, we summarize recent findings on the role of DNA methylation in the fibrotic, angiogenic, inflammatory/immune, and stem cell microenvironments of HCC, and discuss new advances in Traditional Chinese Medicine (TCM) on influencing the abnormal LRM, so as to gain new insights into alleviating the abnormal LRM via regulating DNA methylation by TCM.
Collapse
Affiliation(s)
- Minggang Wang
- Hubei University of Traditional Chinese Medicine, Wuhan, Hubei, China (mainland)
| | - Qianling Ye
- Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China (mainland)
| | - Dewen Mao
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China (mainland)
| | - Hanmin Li
- Hubei University of Traditional Chinese Medicine, Wuhan, Hubei, China (mainland)
| |
Collapse
|
5
|
Zhang F, Wang F, Liang B, Li Z, Shao J, Zhang Z, Wang S, Zheng S. Liver regeneration in traditional Chinese medicine: advances and challenges. Regen Med Res 2020; 8:1. [PMID: 31939733 PMCID: PMC6961567 DOI: 10.1051/rmr/190003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Accepted: 12/10/2019] [Indexed: 11/14/2022] Open
Abstract
Liver diseases pose a serious problem for national health care system all over the world. Liver regeneration has profound impacts on the occurrence and development of various liver diseases, and it remains an extensively studied topic. Although current knowledge has suggested two major mechanisms for liver regeneration, including compensatory hyperplasia of hepatocytes and stem or progenitor cell-mediated regeneration, the complexity of this physiopathological process determines that its effective regulation cannot be achieved by single-target or single-component approaches. Alternatively, using traditional Chinese medicine (TCM) to regulate liver regeneration is an important strategy for prevention and treatment of liver disorder and the related diseases. From the perspectives of TCM, liver regeneration can be caused by the disrupted balance between hepatic damage and regenerative capacity, and the "marrow"-based approaches have important therapeutic implications for liver regeneration. These two points have been massively supported by a number of basic studies and clinical observations during recent decades. TCM has the advantages of overall dynamic fine-tuning and early adjustment, and has exhibited enormous therapeutic benefits for various liver diseases. Here, we review the recent advances in the understanding of liver regeneration in TCM system in the hope of facilitating the application of TCM for liver diseases via regulation of liver regeneration.
Collapse
Affiliation(s)
- Feng Zhang
-
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
-
Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
-
State Key Laboratory Cultivation Base for TCM Quality and Efficacy, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
| | - Feixia Wang
-
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
| | - Baoyu Liang
-
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
| | - Zhanghao Li
-
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
| | - Jiangjuan Shao
-
Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
-
State Key Laboratory Cultivation Base for TCM Quality and Efficacy, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
| | - Zili Zhang
-
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
-
Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
-
State Key Laboratory Cultivation Base for TCM Quality and Efficacy, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
| | - Shijun Wang
-
Shandong Co-innovation Center of TCM Formula, College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine Jinan 250355 PR China
| | - Shizhong Zheng
-
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
-
Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
-
State Key Laboratory Cultivation Base for TCM Quality and Efficacy, School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023 PR China
| |
Collapse
|
6
|
Zhao BB, Ye ZH, Gao X, Li HM. Diwu Yanggan Modulates the Wnt/β-catenin Pathway and Inhibits Liver Carcinogenesis Signaling in 2-AAF/PH Model Rats. Curr Med Sci 2019; 39:913-919. [PMID: 31845222 DOI: 10.1007/s11596-019-2123-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Revised: 10/11/2019] [Indexed: 02/07/2023]
Abstract
The activation of the Wnt/β-catenin signaling pathway in oval cells after liver injury is implicated in hepatocarcinogenesis. Diwu Yanggan capsule is a Chinese herbal medicine that has been used for treating liver disorder. The present study aimed to examine the mechanism by which Diwu Yanggan inhibits liver carcinogenesis, and the involvement of the Wnt/β-catenin signaling pathway. Diwu Yanggan capsule was administered to 2-acetaminofluorene/partial hepatectomy (2-AAF/PH) rats, a murine model of liver injury. The biomarkers of oval cells and key proteins in the Wnt/β-catenin signaling pathway were assessed on postoperative day 8, 10, 14, 17, 19 and 22. The results showed that treatment with Diwu Yanggan was associated with reduced expression of oval cell and stem cell biomarkers in the 2-AAF/PH animals. The expression pattern of key proteins in the Wnt/β-catenin pathway was altered in Diwu Yanggan-treated animals, indicating that the Diwu Yanggan treatment accelerated the activation of the Wnt/β-catenin pathway in the initial stage and contributed to its deactivation in the later stage. Histological findings indicated that hepatocyte proliferation was suppressed in Diwu Yanggan-treated animals, compared with untreated 2-AAF/PH animals. Taken together, Diwu Yanggan capsule may reduce the risk of hepatocarcinogenesis by modulating the Wnt/β-catenin signaling pathway.
Collapse
Affiliation(s)
- Bin-Bin Zhao
- Basic Medicine College, Hubei University of Traditional Chinese Medicine, Wuhan, 430065, China
| | - Zhi-Hua Ye
- Hepatology Institute, Hubei Provincial Hospital of Traditional Chinese Medicine & Affiliated Hospital to Hubei University of Traditional Chinese Medicine, Hubei Institute of Traditional Chinese Medicine, Wuhan, 430061, China
| | - Xiang Gao
- Hepatology Institute, Hubei Provincial Hospital of Traditional Chinese Medicine & Affiliated Hospital to Hubei University of Traditional Chinese Medicine, Hubei Institute of Traditional Chinese Medicine, Wuhan, 430061, China
| | - Han-Min Li
- Hepatology Institute, Hubei Provincial Hospital of Traditional Chinese Medicine & Affiliated Hospital to Hubei University of Traditional Chinese Medicine, Hubei Institute of Traditional Chinese Medicine, Wuhan, 430061, China.
| |
Collapse
|
7
|
Zhao BB, Chen LL, Long QH, Xie GJ, Xu B, Li ZF, Wang P, Li H. Preventive Effects of Escitalopram Against Anxiety-Like Depressive Behaviors in Monosodium Glutamate-Teated Rats Subjected to Partial Hepatectomy. Front Psychol 2019; 10:2462. [PMID: 31798487 PMCID: PMC6861546 DOI: 10.3389/fpsyg.2019.02462] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Accepted: 10/17/2019] [Indexed: 12/15/2022] Open
Abstract
The reasons for the relationship between depression and chronic liver disease (CLD) are complex and multifactorial. Further research is needed to decipher the etiology and establish an optimal management approach for depression in patients, including the potential role of non-pharmacological treatments. monosodium glutamate (MSG)-treated rats are more likely to develop anxiogenic- and depressive-like behaviors, which could be related to the dysfunction of serotonergic system. In this study, partial hepatectomy (PH) was performed in MSG-treated rats and the histopathological changes were observed in orbitofrontal cortex (OFC) and liver. The effect of escitalopram, a widely used antidepressant, on neural and liver injury in this model was also examined. The MSG + PH-treated rats displayed decreased distances traveled in total, in center arena, and in the left side of arena in inner open field test (OFT), as compared to saline, saline + PH, and MSG-treated animals. The present study established that PH aggravated anxiety-like depressive behaviors in MSG-treated rats, concordant with damaged Nissl bodies (and neurites), decreased IBA-1 and Sox-2 expression in OFC and neurotransmitter disorder. Escitalopram treatment could alleviate these pathological changes as well as reduce hepatic steatosis and lipid metabolism.
Collapse
Affiliation(s)
- Bin-Bin Zhao
- Hubei University of Chinese Medicine, Wuhan, China
| | - Lin-Lin Chen
- Hubei University of Chinese Medicine, Wuhan, China
| | | | | | - Bo Xu
- Hubei University of Chinese Medicine, Wuhan, China
| | - Ze-Fei Li
- Hubei University of Chinese Medicine, Wuhan, China
| | - Ping Wang
- Hubei University of Chinese Medicine, Wuhan, China
| | - Hanmin Li
- Hubei Hospital of Traditional Chinese Medicine (Affiliated Hospital of Hubei University of Traditional Chinese Medicine), Hubei University of Chinese Medicine, Wuhan, China
| |
Collapse
|
8
|
Chang M, Wu M, Li H. Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice. Drug Deliv 2019; 25:1984-1995. [PMID: 30499350 PMCID: PMC6282420 DOI: 10.1080/10717544.2018.1526227] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
At present, the chemotherapy of advanced inoperable liver cancer is limited with serious side effects. Curcumin possesses multiple cancer preventive activities and low safety concerns. However, its poor solubility and instability in water pose significant pharmacological barriers to its clinical application. In this study, we presented a novel delivery system – the glycyrrhetinic acid modified curcumin-loaded cationic liposomes (GAMCLCL) and investigated its antitumor activities on HepG2 cells in vitro and in H22 tumor-bearing mice. The experimental results demonstrated that GAMCLCL was a cationic liposome and could be Intravenous administration. Compared to free curcumin, GAMCLCL exhibited stronger antitumor activities in vitro and in vivo. The antitumor results of GAMCLCL after intravenous administration were very similar to those after intratumoral administration. The main activities of GAMCLCL and curcumin included inhibition of HepG2 cell proliferation, inhibition of tumor growth, reduction of tumor microvascular density, down-regulation of the expression of VEGF protein, and up-regulation of the expression of Caspases3 protein in H22 tumor tissues. Furthermore, GAMCLCL improved the parameters of WBC, RBC, ALT, CRE, LDH of H22 tumor-bearing mice. Curcumin is a nontoxic natural compound with definite antitumor activities, its antitumor effects can be enhanced by preparation of GAMCLCL.
Collapse
Affiliation(s)
- Mingxiang Chang
- a First clinical medical school , Hubei University of Chinese Medicine , Wuhan , P.R. China.,b Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , P.R. China.,c Hubei Province Academy of Traditional Chinese Medicine , Wuhan , P.R.China
| | - Meimei Wu
- b Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , P.R. China.,c Hubei Province Academy of Traditional Chinese Medicine , Wuhan , P.R.China
| | - Hanmin Li
- b Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , P.R. China.,c Hubei Province Academy of Traditional Chinese Medicine , Wuhan , P.R.China
| |
Collapse
|
9
|
Ye Z, Gao X, Zhao B, Li H, Wan M, Wu N, Chang M, Cheng S. Diwu Yanggan capsule inhibits the occurrence and development of liver cancer in the Solt-Farber rat model by regulating the Ras/Raf/Mek/Erk signaling pathway. Am J Transl Res 2018; 10:3797-3805. [PMID: 30662630 PMCID: PMC6291696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Accepted: 10/22/2018] [Indexed: 06/09/2023]
Abstract
This study sought to determine the effect and explore the mechanism of the Chinese medicinal compound preparation Diwu Yanggan (DWYG) capsule on the occurrence and development of liver cancer using the Solt-Farber rat model. Sprague-Dawley rats were randomly distributed into a normal group, sham group, DWYG group, sorafenib group, and model group. The DWYG group and sorafenib group were given DWYG capsule and sorafenib tablet, respectively, with induction of the model. Hematoxylin-eosin (HE) staining was used to detect liver pathological changes. The content of nuclear DNA in the liver was detected by Feulgen staining, and the expression of PCNA was detected by immunohistochemical staining. Molecular biology methods were used to detect the expression of liver regeneration-related factors and Ras/Raf/Mek/Erk signaling pathway-related proteins and mRNAs. HE staining showed that compared with those in the model group, the liver pathological changes in the DWYG group were significantly reduced (P < 0.05). The nuclear DNA content in the liver based on Feulgen staining and the expression of PCNA in the DWYG group was lower than that in the model group (P < 0.05). The expression of regeneration-related factors and Ras/Raf/Mek/Erk signaling pathway-related proteins and mRNAs was significantly lower in the DWYG group than in the model group (P < 0.05). In conclusion, DWYG capsules to some degree inhibit the occurrence and development of liver cancer in the Solt-Farber rat model, and the effect is not inferior to that of sorafenib. DWYG capsules likely delay the occurrence and development of liver cancer and improve the liver regeneration microenvironment by regulating the Ras/Raf/Mek/Erk signaling pathway and regeneration-related factors.
Collapse
Affiliation(s)
- Zhihua Ye
- National Level-3 Laboratory of Cell Molecular Biology of Traditional Chinese Medicine Research, Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Xiang Gao
- National Level-3 Laboratory of Cell Molecular Biology of Traditional Chinese Medicine Research, Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Binbin Zhao
- Hubei University of Chinese MedicineWuhan 430065, Hubei Province, China
| | - Hanmin Li
- National Level-3 Laboratory of Cell Molecular Biology of Traditional Chinese Medicine Research, Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Ming Wan
- National Level-3 Laboratory of Cell Molecular Biology of Traditional Chinese Medicine Research, Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Na Wu
- Hubei University of Chinese MedicineWuhan 430065, Hubei Province, China
| | - Mingxiang Chang
- Hubei University of Chinese MedicineWuhan 430065, Hubei Province, China
| | - Sisi Cheng
- The Eighth Hospital of WuhanWuhan 430010, Hubei Province, China
| |
Collapse
|
10
|
Li HM. Liver regeneration microenvironment in liver cancer: Research progress and prospect. Shijie Huaren Xiaohua Zazhi 2018; 26:1529-1536. [DOI: 10.11569/wcjd.v26.i26.1529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
The proposal of the new concept of liver regeneration microenvironment in liver cancer (LC) contributes to the overall understanding of how LC microenvironment influences the occurrence and development of LC through liver regeneration microenvironment, inflammatory microenvironment, immune microenvironment, and angiogenesis microenvironment, and helps explore more comprehensive and effective preventive and therapeutic measures for LC to improve the capability of LC prevention and cure. On the basis of eliminating hepatocellular carcinoma cells or tissues, the maintenance of normal liver regeneration and improvement of liver regeneration microenvironment in LC is an important strategy for LC prevention and treatment. Improving liver regeneration microenvironment to prevent or reverse the occurrence, development, and metastasis of LC should be an important research direction of LC prevention and treatment research. In recent years, traditional Chinese medicine research and application have made some progress in improving liver regeneration microenvironment to prevent or reverse the occurrence, development, recurrence, and metastasis of LC. However, it remains to be solved on how to accurately reveal the comprehensive network mechanism and how to provide advanced evidence-based medical evidence, which needs further extensive research.
Collapse
Affiliation(s)
- Han-Min Li
- Institute of Liver Diseases and Institute of Traditional Chinese Medicine Basic Theory, Hubei Provincial Hospital of Traditional Chinese Medicine (Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine), Wuhan 430061, Hubei Province, China
| |
Collapse
|
11
|
Protective Effects of Liu Wei Di Huang Wan on the Liver, Orbitofrontal Cortex Nissl Bodies, and Neurites in MSG+PH-Induced Liver Regeneration Rat Model. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2018; 2018:9090128. [PMID: 30224933 PMCID: PMC6129786 DOI: 10.1155/2018/9090128] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/01/2018] [Accepted: 06/03/2018] [Indexed: 01/05/2023]
Abstract
Introduction. To examine the protective effects of Liu Wei Di Huang Wan formula (LWDH) on liver and orbitofrontal cortex (OFC) injuries in monosodium glutamate (MSG) and partial hepatectomy (PH) rat model. Methods. Neonatal Wistar rats were given MSG or saline on postnatal days 2, 4, 6, 8, and 10. The rats were caged into five groups and treated accordingly at six weeks old as follows: Saline group, Saline+PH group, MSG group, MSG+PH group, and LWDH group (MSG+PH+LWDH). The PH was performed during week 8 by excision of the left and median hepatic lobes (occupying about 68% of whole liver).On day 8 after the PH, the rats were subjected to an inner OFT before being sacrificed. The liver and OFC were stained using H&E, ORO, or Nissl staining. The expression of neurotrophic factors (β-NGF, BDNF) was examined in the OFC lysates by ELISA. Serum levels of cytokines (IL-1β, VEGF) were examined using the Bio-Plex suspension array. Results. LWDH increased the total distance traveled by the animals (p<0.05), and LWDH improved the integrity of the Nissl bodies in the OFC (mean area of the Nissl bodies, p<0.01; mean diameter, p<0.05; mean density, p<0.05; and IOD, p<0.01). There were less white area in the liver (p>0.05) and decreased hepatic steatosis (p<0.01) in LWDH group. LWDH administration decreased the expression of serum levels of IL-1β (p>0.05), while it increased VEGF (p>0.05) expression. LWDH administration increased the expression of BDNF (p>0.05) and β-NGF (p>0.05) in the OFC, all as compared to the MSG+PH group. Conclusion. LWDH partly protected the animals from depressive-like behaviors in the MSG+PH-induced liver regeneration neonatal rat model. LWDH alleviated hepatic injury and steatosis and, furthermore, protected the Nissl body integrity and the growth of neurites.
Collapse
|
12
|
Li H, Ye Z, Gao X, Zhang L, Yao X, Gu J, Lu D, Wan M, Xiao L, Cai W, Yan X, Zhao B, Wu Y, Zhang J. Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial. Am J Transl Res 2018; 10:1511-1521. [PMID: 29887964 PMCID: PMC5992542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2017] [Accepted: 02/27/2018] [Indexed: 06/08/2023]
Abstract
The number of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) has shown a significant upward trend in recent years. However, antiviral drugs are not very effective. Regulation of liver regeneration by traditional Chinese medicine is an important way to improve clinical efficacy. This randomized controlled trial assessed the efficacy and safety of DWYG in patients with HBeAg-negative CHB. Overall, 130 subjects were randomized to (A) DWYG 1.2 g three times daily (n = 44), (B) entecavir 0.5 mg/day (n = 43) in combination with DWYG or (C) entecavir 0.5 mg/day (n = 43). The liver histological response rate was assessed as the primary efficacy endpoint. The results showed that the liver histological response rate in the combination treatment group was significantly higher than that in the group with entecavir (71.43% versus 22.22%; P = 0.036) after 48 weeks of treatment. And the pathological progression rate of liver in the group with DWYG was significantly lower than that of the entecavir group during 228 weeks of follow-up (0% versus 60.00%; P = 0.019). No significant adverse events occurred during the study. In conclusion, treating HBeAg-negative CHB with DWYG is safe and effective to improve liver histological response.
Collapse
Affiliation(s)
- Hanmin Li
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Zhihua Ye
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Xiang Gao
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Lisheng Zhang
- College of Veterinary Medicine, Huazhong Agricultural UniversityWuhan 430070, Hubei Province, China
| | - Xin Yao
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Jianxun Gu
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Dingbo Lu
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Ming Wan
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Lin Xiao
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Wangxi Cai
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Xuesheng Yan
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Binbin Zhao
- Basic Medical College, Hubei University of Chinese MedicineWuhan 430065, Hubei Province, China
| | - Yu Wu
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| | - Jinrong Zhang
- Hubei Provincial Hospital of Traditional Chinese MedicineWuhan 430061, Hubei Province, China
- Hubei Province Academy of Traditional Chinese MedicineWuhan 430074, Hubei Province, China
| |
Collapse
|
13
|
Abstract
中医药调控肝再生是防治肝病及其相关病证的重要策略, 已形成的研究热点方兴未艾. 近些年来取得的主要进展至少包括以下几个方面: 调控肝损伤与肝再生失衡提高了中医/中西医结合防治肝病及其相关病证的临床疗效, "髓"为中心治疗靶点的研究进展揭示了中医/中西医结合防治肝病及其相关病证的疗效机制, 整体动态微调早调的作用方式满足了肝再生调控复杂多变的需要, 解决了单靶点调控肝再生疗效有限的关键科学问题, 平衡协调的疗效考核与结局指标的综合判断为中医药调控肝再生的临床推广应用提供了途径和方法.
Collapse
|
14
|
Li HM. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine. Chin J Integr Med 2016; 22:163-7. [PMID: 26919996 DOI: 10.1007/s11655-016-2460-y] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2015] [Indexed: 01/30/2023]
Abstract
Microcirculation of liver cancer is the micro-vascular system which comes from the tissue of liver cancer. It can offer the nutritional requirement for accelerating the cancer cell proliferation and metastasis. The intrinsic mechanism of angiogenesis is the key link in the formation of liver cancer microcirculation system. Liver regeneration microenvironment also plays an important role in the construction of liver cancer microcirculation, through the improvement of liver regeneration microenvironment affecting tumor microcirculation is the new strategy of prevention and treatment of liver cancer. In recent years, it is found that many kinds of Chinese medicine can inhibit angiogenesis, decrease the microvessel density, and delay or prevent the development of liver cancer.
Collapse
Affiliation(s)
- Han-min Li
- Institute of Liver Diseases of Hubei Provincial Hospital of Traditional Chinese Medicine, National Scientific Research Level-3 Laboratory of Cell and Molecular Biology of Traditional Chinese Medicine, Key Research Office of the State Administration of Traditional Chinese Medicine on the Treatment of Chronic Liver Diseases on the Dialectical Thought of Liver and Kidney, Wuhan, China
| |
Collapse
|
15
|
Abstract
This paper aims to review the progress and problems in research of liver regeneration regulation in recent years and to explore the solutions to these problems by performing a systematic literature review combined with the author's work. In recent years, great progress has been made in preventing and treating liver diseases by regulating liver regeneration, for example, the coordination of promotion and inhibition, the reverse inhibition and positive induction, slight adjustment and preconditioning, and overall dynamic control. Current key scientific problems in this field include distinguishing between abnormal and normal liver regeneration, mechanisms underlying their mutual transformation, objective criteria for clinical application, and quantitative indicators for judging the efficacy. The regulation of liver regeneration for preventing and treating liver diseases has become a hot research topic, and the clinical translation and application of studies remain to be promoted on the basis of further in-depth research.
Collapse
|